Key result
Circulating circular RNAs were significantly elevated in patients with essential hypertension and carotid plaque compared to healthy controls, with hsa_circ_0109569 demonstrating an AUC of 0.741.
Why the study?
No early diagnostic markers for essential hypertension-induced subclinical target organ damage, such as carotid plaque, are currently available.
Do circulating circular RNAs have diagnostic value as biomarkers for essential hypertension with carotid plaque?
Case-Control (n=200)
Do circulating circular RNAs have diagnostic value as biomarkers for essential hypertension with carotid plaque?
Circulating circRNAs, particularly hsa_circ_0109569, show potential as noninvasive biomarkers for the early detection of essential hypertension-induced subclinical target organ damage such as carotid plaque.
May support circRNA biomarker exploration in EH; leaves open diagnostic utility without prospective validation.
Background At present, no early diagnostic markers for essential hypertension (EH)-induced subclinical target organs damage (such as carotid plaque) are available. This study aimed to identify the circular RNAs (circRNAs) in EH with carotid plaques, and assess their utility as biomarkers.Methods First, circRNAs were identified through microarry analysis and database prediction. Second, a case-control study of EH patients with carotid plaque (n = 100) and healthy controls (n = 100) was performed to evaluate circRNAs expression in peripheral blood. Finally, receiver operating characteristic (ROC) curve was established to evaluate the diagnostic value.Results Five circRNAs (hsa_circ_0105130, hsa_circ_0109569, hsa_circ_0072659, hsa_circ_0079586 and hsa_circ_0064684) were identified as the candidate circRNAs. We found that circRNAs were increased in case group compared with controls (P < .05). The results of ROC shown that these five circRNAs, especially hsa_circ_0109569 (AUC = 0.741), all had the moderate predictive value.Conclusions Our study revealed circulating circRNAs may act as promising noninvasive biomarkers for early detection and population screening of EH-induced subclinical target organ injury.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2022) conducted a case-control in Essential hypertension with carotid plaque (n=200). Circulating circular RNAs vs. Healthy controls was evaluated on Diagnostic value for essential hypertension with carotid plaque (AUC 0.741, p=<.05). Circulating circular RNAs were significantly elevated in patients with essential hypertension and carotid plaque compared to healthy controls, with hsa_circ_0109569 demonstrating an AUC of 0.741.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: